Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
SI-BONE, Inc. develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy. The company offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $73.4M | $90.2M | $106.4M | $138.9M | $167.2M | $200.9M |
| Gross profit | $64.5M | $79.7M | $90.7M | $109.4M | $132.1M | $159.9M |
| Operating income | -$38.6M | -$51.7M | -$59.6M | -$46.9M | -$35.2M | -$22.3M |
| Net income | -$43.7M | -$56.6M | -$61.3M | -$43.3M | -$30.9M | -$18.9M |
| Diluted EPS | -$1.50 | -$1.71 | -$1.79 | -$1.13 | -$0.75 | -$0.44 |
| Operating cash flow | -$30.7M | -$39.5M | -$41.7M | -$18.7M | -$12.4M | -$675,000.00 |
| Free cash flow | -$33.2M | -$45.9M | -$51.2M | -$26.5M | -$22.9M | -$9.1M |
| Gross margin | 87.9% | 88.4% | 85.2% | 78.8% | 79.0% | 79.6% |
| Operating margin | -52.6% | -57.3% | -56.0% | -33.8% | -21.1% | -11.1% |
| Net margin | -59.5% | -62.8% | -57.6% | -31.2% | -18.5% | -9.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $40.0M | $40.3M | $49.0M | $47.3M | $48.6M | $48.7M | $56.3M | $52.6M |
| Gross profit | $31.6M | $31.9M | $38.8M | $37.7M | $38.8M | $38.8M | $44.5M | $41.9M |
| Operating income | -$10.1M | -$7.6M | -$5.5M | -$7.5M | -$7.0M | -$5.4M | -$2.5M | -$5.1M |
| Net income | -$8.9M | -$6.6M | -$4.5M | -$6.5M | -$6.2M | -$4.6M | -$1.6M | -$4.3M |
| Diluted EPS | -$0.22 | -$0.16 | -$0.10 | -$0.15 | -$0.14 | -$0.11 | -$0.04 | -$0.10 |
| Operating cash flow | -$6.3M | $302,000.00 | $1.2M | -$4.9M | $173,000.00 | $2.3M | $1.7M | -$2.4M |
| Free cash flow | -$9.4M | -$2.7M | -$1.1M | -$7.0M | -$1.9M | -$620,000.00 | $440,000.00 | -$3.4M |
| Gross margin | 79.0% | 79.1% | 79.1% | 79.7% | 79.8% | 79.8% | 79.0% | 79.8% |
| Operating margin | -25.2% | -18.9% | -11.2% | -15.8% | -14.4% | -11.1% | -4.4% | -9.7% |
| Net margin | -22.4% | -16.3% | -9.1% | -13.8% | -12.7% | -9.4% | -2.9% | -8.2% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-02 | Pisetsky Michael A· SVP, Ops & Adm/Chief Legal Ofr | Sale | 1,799 | $16.70 | $30,041.86 | filing |
| 2026-07-02 | Maheshwari Anshul· Chief Financial Officer | Sale | 1,757 | $16.80 | $29,520.59 | filing |
| 2026-07-02 | Maheshwari Anshul· Chief Financial Officer | Sale | 1,560 | $16.73 | $26,106.29 | filing |
| 2026-07-02 | Pisetsky Michael A· SVP, Ops & Adm/Chief Legal Ofr | Sale | 1,301 | $16.73 | $21,760.01 | filing |
| 2026-07-02 | Pisetsky Michael A· SVP, Ops & Adm/Chief Legal Ofr | Sale | 34 | $16.86 | $573.24 | filing |
| 2026-06-05 | DUNN JEFFREY W | Sale | 3,575 | $15.25 | $54,505.17 | filing |
| 2026-06-04 | DUNN JEFFREY W | Award | 10,957 | $0.00 | $0.00 | filing |
| 2026-06-04 | HILLEMAN JERYL L | Award | 10,957 | $0.00 | $0.00 | filing |
| 2026-06-04 | Nishimura Mika | Award | 10,957 | $0.00 | $0.00 | filing |
| 2026-06-04 | West Thomas A. | Award | 10,957 | $0.00 | $0.00 | filing |
| 2026-06-04 | Freund John Gordon | Award | 10,957 | $0.00 | $0.00 | filing |
| 2026-06-04 | Davis Timothy E JR | Award | 10,957 | $0.00 | $0.00 | filing |
| 2026-05-29 | Davis Timothy E JR | Sale | 3,500 | $14.14 | $49,487.90 | filing |
| 2026-05-28 | Davis Timothy E JR | Sale | 3,780 | $14.47 | $54,698.87 | filing |
| 2026-05-28 | Davis Timothy E JR | Option exercise | 12,064 | $4.32 | $52,116.48 | filing |
| 2026-05-18 | FRANCIS LAURA· Chief Executive Officer | Sale | 3,893 | $14.75 | $57,403.45 | filing |
| 2026-05-18 | FRANCIS LAURA· Chief Executive Officer | Sale | 3,652 | $14.75 | $53,866.63 | filing |
| 2026-05-18 | FRANCIS LAURA· Chief Executive Officer | Sale | 3,203 | $14.73 | $47,171.54 | filing |
| 2026-05-18 | Maheshwari Anshul· Chief Financial Officer | Sale | 2,477 | $14.71 | $36,444.60 | filing |
| 2026-05-18 | FRANCIS LAURA· Chief Executive Officer | Sale | 2,236 | $14.67 | $32,813.08 | filing |
| 2026-05-18 | Maheshwari Anshul· Chief Financial Officer | Sale | 2,189 | $14.65 | $32,078.70 | filing |
| 2026-05-18 | FRANCIS LAURA· Chief Executive Officer | Sale | 1,973 | $14.57 | $28,745.43 | filing |
| 2026-05-18 | Pisetsky Michael A· SVP, Ops & Adm/Chief Legal Ofr | Sale | 1,872 | $14.63 | $27,392.41 | filing |
| 2026-05-18 | Pisetsky Michael A· SVP, Ops & Adm/Chief Legal Ofr | Sale | 1,854 | $14.64 | $27,134.40 | filing |
| 2026-05-04 | DUNN JEFFREY W | Sale | 337 | $13.15 | $4,431.82 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.